{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:39:33Z","timestamp":1792705173925,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Rayner Surgical Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"DOI":"10.1007\/s40123-026-01525-8","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:38:40Z","timestamp":1792658320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aqueous and Vitreous Ketorolac Levels in Combined Cataract and Pars Plana Vitrectomy with Intracameral Ketorolac 0.3% Versus Topical Ketorolac 0.4%"],"prefix":"10.1007","clinical-trial-number":[{"clinical-trial-number":"nct06539637","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Eric D.","family":"Donnenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahas","family":"Narain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Shoshany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry D.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Butterworth","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"11","key":"1525_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1517\/17425247.2015.1068756","volume":"12","author":"F Semeraro","year":"2015","unstructured":"Semeraro F, Russo A, Gambicorti E, et al. Efficacy and vitreous levels of topical NSAIDs. Expert Opin Drug Deliv. 2015;12(11):1767\u201382.","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"1525_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.survophthal.2020.02.004","volume":"65","author":"G Hollo","year":"2020","unstructured":"Hollo G, Aung T, Cantor LB, Aihara M. Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management. Surv Ophthalmol. 2020;65(5):496\u2013512. https:\/\/doi.org\/10.1016\/j.survophthal.2020.02.004.","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"1525_CR3","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.ophtha.2015.05.014","volume":"122","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Schoenberger SD, Thorne JE, et al. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122(11):2159\u201368. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.014.","journal-title":"Ophthalmology"},{"issue":"5","key":"1525_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s10792-016-0374-5","volume":"37","author":"N Cardascia","year":"2017","unstructured":"Cardascia N, Palmisano C, Centoducati T, Alessio G. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery. Int Ophthalmol. 2017;37(5):1127\u201331. https:\/\/doi.org\/10.1007\/s10792-016-0374-5.","journal-title":"Int Ophthalmol"},{"issue":"12","key":"1525_CR5","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.ophtha.2015.08.024","volume":"122","author":"NH Shorstein","year":"2015","unstructured":"Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgery. Ophthalmology. 2015;122(12):2450\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2015.08.024.","journal-title":"Ophthalmology"},{"issue":"4","key":"1525_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcrs.2018.01.029","volume":"44","author":"LHP Wielders","year":"2018","unstructured":"Wielders LHP, Schouten J, Winkens B, et al. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg. 2018;44(4):429\u201339. https:\/\/doi.org\/10.1016\/j.jcrs.2018.01.029.","journal-title":"J Cataract Refract Surg"},{"key":"1525_CR7","doi-asserted-by":"publisher","unstructured":"Bucci FA, Jr., Michalek B, Fluet AT. Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%\/0.3% at the time of routine cataract surgery. Clin Ophthalmol. 2017;11:1039\u201343. https:\/\/doi.org\/10.2147\/OPTH.S132552.","DOI":"10.2147\/OPTH.S132552"},{"key":"1525_CR8","unstructured":"U.S. Food and Drug Administration. OMIDRIA\u00ae (phenylephrine and ketorolac intraocular solution) 1%\/0.3% Prescribing information; 2014. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/205388s006lbl.pdf. Accessed 17 Dec 2025."},{"issue":"10","key":"1525_CR9","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jcrs.2015.10.053","volume":"41","author":"JA Hovanesian","year":"2015","unstructured":"Hovanesian JA, Sheppard JD, Trattler WB, et al. Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: integrated results from 2 pivotal phase 3 studies. J Cataract Refract Surg. 2015;41(10):2060\u20138. https:\/\/doi.org\/10.1016\/j.jcrs.2015.10.053.","journal-title":"J Cataract Refract Surg"},{"key":"1525_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2147\/OPTH.S72321","volume":"9","author":"LE Lawuyi","year":"2015","unstructured":"Lawuyi LE, Gurbaxani A. The clinical utility of new combination phenylephrine\/ketorolac injection in cataract surgery. Clin Ophthalmol. 2015;9:1249\u201354. https:\/\/doi.org\/10.2147\/OPTH.S72321.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"1525_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jcrs.2017.02.030","volume":"43","author":"ED Donnenfeld","year":"2017","unstructured":"Donnenfeld ED, Whitaker JS, Jackson MA, Wittpenn J. Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgery. J Cataract Refract Surg. 2017;43(5):597\u2013605. https:\/\/doi.org\/10.1016\/j.jcrs.2017.02.030.","journal-title":"J Cataract Refract Surg"},{"key":"1525_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/OPTH.S149581","volume":"12","author":"ED Rosenberg","year":"2018","unstructured":"Rosenberg ED, Nattis AS, Alevi D, et al. Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%\/ketorolac 0.3% administered during cataract surgery. Clin Ophthalmol. 2018;12:21\u20138. https:\/\/doi.org\/10.2147\/OPTH.S149581.","journal-title":"Clin Ophthalmol"},{"key":"1525_CR13","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2147\/OPTH.S422502","volume":"17","author":"ED Donnenfeld","year":"2023","unstructured":"Donnenfeld ED, Hovanesian JA, Malik AG, Wong A. A randomized, prospective, observer-masked study comparing dropless treatment regimen using intracanalicular dexamethasone insert, intracameral ketorolac, and intracameral moxifloxacin versus conventional topical therapy to control postoperative pain and inflammation in cataract surgery. Clin Ophthalmol. 2023;17:2349\u201356. https:\/\/doi.org\/10.2147\/OPTH.S422502.","journal-title":"Clin Ophthalmol"},{"key":"1525_CR14","unstructured":"Visser N. Dropless cataract surgery: preliminary results of the ESCRS EPICAT study. In: Presented at: 42nd Congress of the ESCRS, September 7, 2024, Barcelona, Spain"},{"issue":"9","key":"1525_CR15","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1097\/IAE.0b013e3181b094e6","volume":"29","author":"JS Heier","year":"2009","unstructured":"Heier JS, Awh CC, Busbee BG, et al. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%. Retina. 2009;29(9):1310\u20133. https:\/\/doi.org\/10.1097\/IAE.0b013e3181b094e6.","journal-title":"Retina"},{"key":"1525_CR16","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2147\/OPTH.S149523","volume":"11","author":"DA Katsev","year":"2017","unstructured":"Katsev DA, Katsev CC, Pinnow J, Lockhart CM. Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administration. Clin Ophthalmol. 2017;11:1897\u2013901. https:\/\/doi.org\/10.2147\/OPTH.S149523.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1525_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2025.2476866","volume":"11","author":"P Pandey","year":"2025","unstructured":"Pandey P, White BA, Goswell C, et al. Bioanalytical method validation to quantify ketorolac in human vitreous and aqueous via surrogate matrix of human plasma. Future Sci OA. 2025;11(1):2476866. https:\/\/doi.org\/10.1080\/20565623.2025.2476866.","journal-title":"Future Sci OA"},{"issue":"1","key":"1525_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3928\/23258160-20221214-02","volume":"54","author":"K Mishra","year":"2023","unstructured":"Mishra K, Velez G, Chemudupati T, et al. Intraoperative complications with vitreous biopsy for molecular proteomics. Ophthalmic Surg Lasers Imaging Retina. 2023;54(1):32\u20136. https:\/\/doi.org\/10.3928\/23258160-20221214-02.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"2","key":"1525_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1208\/s12248-022-00694-1","volume":"24","author":"EA Dubiel","year":"2022","unstructured":"Dubiel EA, Myler H, Arnold ME, et al. Biological matrix supply chain shortages: more matrices are now rare-the case for surrogate matrices. AAPS J. 2022;24(2):42. https:\/\/doi.org\/10.1208\/s12248-022-00694-1.","journal-title":"AAPS J"},{"issue":"5","key":"1525_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10384-025-01220-4","volume":"69","author":"M Simsek","year":"2025","unstructured":"Simsek M, Cakir GY, Koser E, Altan C, Taskapili M. Quantitative evaluation of inflammation after phacoemulsification surgery: anterior chamber flare and choroidal vascular index. Jpn J Ophthalmol. 2025;69(5):813\u201322. https:\/\/doi.org\/10.1007\/s10384-025-01220-4.","journal-title":"Jpn J Ophthalmol"},{"key":"1525_CR21","doi-asserted-by":"publisher","unstructured":"Salavat MC, Munteanu M, Chercota V, et al. Corneal endothelial cell loss following cataract surgery in patients with type 2 diabetes mellitus: a comprehensive review. Biomedicines. 2025;13(7). https:\/\/doi.org\/10.3390\/biomedicines13071726.","DOI":"10.3390\/biomedicines13071726"},{"issue":"10","key":"1525_CR22","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.jcrs.2015.10.056","volume":"41","author":"T Kohnen","year":"2015","unstructured":"Kohnen T. Treating inflammation after lens surgery. J Cataract Refract Surg. 2015;41(10):2035. https:\/\/doi.org\/10.1016\/j.jcrs.2015.10.056.","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"1525_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3928\/1081597X-20131021-03","volume":"29","author":"T Schultz","year":"2013","unstructured":"Schultz T, Joachim SC, Kuehn M, Dick HB. Changes in prostaglandin levels in patients undergoing femtosecond laser-assisted cataract surgery. J Refract Surg. 2013;29(11):742\u20137. https:\/\/doi.org\/10.3928\/1081597X-20131021-03.","journal-title":"J Refract Surg"},{"issue":"2","key":"1525_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3928\/1081597X-20150122-01","volume":"31","author":"T Schultz","year":"2015","unstructured":"Schultz T, Joachim SC, Stellbogen M, Dick HB. Prostaglandin release during femtosecond laser-assisted cataract surgery: main inducer. J Refract Surg. 2015;31(2):78\u201381. https:\/\/doi.org\/10.3928\/1081597X-20150122-01.","journal-title":"J Refract Surg"},{"issue":"1-2","key":"1525_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/jop.2017.0048","volume":"34","author":"LD Waterbury","year":"2018","unstructured":"Waterbury LD. Alternative drug delivery for patients undergoing cataract surgery as demonstrated in a canine model. J Ocul Pharmacol Ther. 2018;34(1\u20132):154\u201360. https:\/\/doi.org\/10.1089\/jop.2017.0048.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"1525_CR26","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1185\/03007995.2011.626018","volume":"27","author":"FA Bucci Jr.","year":"2011","unstructured":"Bucci FA Jr., Waterbury LD. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification. Curr Med Res Opin. 2011;27(12):2235\u20139. https:\/\/doi.org\/10.1185\/03007995.2011.626018.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1525_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","volume":"123","author":"CJ Chu","year":"2016","unstructured":"Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes. Ophthalmology. 2016;123(2):316\u201323. https:\/\/doi.org\/10.1016\/j.ophtha.2015.10.001.","journal-title":"Ophthalmology"},{"issue":"6","key":"1525_CR28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/IAE.0b013e318169d04e","volume":"28","author":"SJ Kim","year":"2008","unstructured":"Kim SJ, Belair ML, Bressler NM, et al. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina. 2008;28(6):870\u20136. https:\/\/doi.org\/10.1097\/IAE.0b013e318169d04e.","journal-title":"Retina"},{"issue":"5","key":"1525_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/01.iae.0000249577.92800.c0","volume":"27","author":"JK Schmier","year":"2007","unstructured":"Schmier JK, Halpern MT, Covert DW, Matthews GP. Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina. 2007;27(5):621\u20138. https:\/\/doi.org\/10.1097\/01.iae.0000249577.92800.c0.","journal-title":"Retina"},{"issue":"6","key":"1525_CR30","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/j.jcrs.0000000000000193","volume":"46","author":"DM Visco","year":"2020","unstructured":"Visco DM, Bedi R. Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. J Cataract Refract Surg. 2020;46(6):867\u201372. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000193.","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"1525_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamaophthalmol.2013.5692","volume":"132","author":"SD Schoenberger","year":"2014","unstructured":"Schoenberger SD, Kim SJ, Sheng J, Calcutt MW. Reduction of vitreous prostaglandin E2 levels after topical administration of ketorolac 0.45%. JAMA Ophthalmol. 2014;132(2):150\u20134. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.5692.","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"1525_CR32","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jcrs.2016.07.014","volume":"42","author":"RS Koplin","year":"2016","unstructured":"Koplin RS, Ritterband DC, Dodick JM, Donnenfeld ED, Schafer M. Untoward events associated with aberrant fluid infusion during cataract surgery: laboratory study with corroborative clinical observations. J Cataract Refract Surg. 2016;42(8):1135\u201340. https:\/\/doi.org\/10.1016\/j.jcrs.2016.07.014.","journal-title":"J Cataract Refract Surg"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01525-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01525-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:02:10Z","timestamp":1792702930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01525-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":32,"alternative-id":["1525"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01525-8","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eric D. Donnenfeld and Sara Butterworth Connell are consultants to Rayner Surgical Inc. Sahas Narain, Talia Shoshany, and Henry D. Perry have no other financial or nonfinancial conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective, randomized, controlled, single-site study was conducted in accordance with the ethical principles described in the Declaration of Helsinki. Before surgery, patients were informed about the risks, benefits, and alternatives to cataract surgery and related medications. The study was approved by the Advarra Institutional Review Board (IRB) (Columbia, MD; IRB approval no. Pro00068701). All patients signed an IRB-approved informed consent form. The trial is registered at ClinicalTrials.gov with the identifier NCT06539637.3.1","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}